Approval · Notice of Compliance 35042 · 2025

SEROQUEL: Notice of Compliance 35042

Issued March 18, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 35042
Date: March 18, 2025
Company: Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Labelling Only
Reason: Administrative: Change in product ownership

Products in this notice

Brand	DIN	Status today
SEROQUEL	02236951	Marketed
SEROQUEL	02236952	Marketed
SEROQUEL	02236953	Marketed
SEROQUEL	02244107	Marketed

Medicinal ingredients

QUETIAPINE FUMARATE 25 MG per TAB
QUETIAPINE FUMARATE 100 MG per TAB
QUETIAPINE FUMARATE 200 MG per TAB
QUETIAPINE FUMARATE 300 MG per TAB